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Summary 
Src homology region 2  (SH2)  domain-containing phosphatase  1  (SHP-1;  previously named 
HCP, PTP1C, SH-PTP1, and SHP) is a cytosolic protein tyrosine phosphatase that contains 
two SH2 domains. Recent data have demonstrated that the gene encoding SHP-1 is mutated 
in motheaten (me) and viable motheaten (me  v) mice resulting in autoimmune disease. More re- 
cently, SHP-1 has been shown to negatively regulate B  cell antigen receptor (BCR.)-initiated 
signaling.  To elucidate potential mechanisms of SHP-1 action in BCR signal transduction, we 
studied proteins that interact with' SHP-1  in B  cells.  Both anti-SHP-1  antibody and the two 
SH2 domains of SHP-1  expressed as glutathione S-transferase fusion proteins precipitated at 
least three phosphoproteins of ~-'75,  110,  and 150 kD upon anti-immunoglobulin M  stimula- 
tion of the WEHI-231  immature B  cell line. Binding of SHP-1  to the 75- and 110-kD pro- 
teins appeared to be mediated mainly by the NH2-terminal SH2 domain of SHP-1, whereas 
both the NH  2- and COOH-terminal  SH2 domains are required for maximal binding to the 
150-kD protein, hnmunoprecipitation and Western blot analysis revealed that the SHP-l-associ- 
ated 75-kD protein is the hematopoietic cell-specific, SH2-containing protein SLP-76.  Fur- 
ther,  this protein-protein association was  constitutively observed and stable  during the  early 
phase of BCl< signaling.  However, significant tyrosine phosphorylation of SLP-76 as well as of 
SHP-1 was observed after BCR. ligation. Constitutive association of SHP-1 with SLP-76 could 
also be detected in normal splenic B  cells.  Collectively, these results  suggest possible mecha- 
nisms by which SHP-1 may modulate signals delivered by BCR engagement. 
E 
ngagement of the B  cell antigen receptor (BCI<) 1 by 
Ag  or  anti-IgM  Ab  rapidly  activates  two  families  of 
protein tyrosine kinases  (PTKs)  associated with  the BCR 
through Ig-et (CD79a) and Ig-[3 (CD79b), including mem- 
bers of the Src-family (Lyn, Blk, Lck, and Fyn) (1-4)  and 
Syk (5, 6). Activation of these PTKs results in phosphoryla- 
tion of a number of downstream substrates  such as phos- 
pholipase Cy (PLCy) (7), phosphatidylinositol 3-kinase (8), 
and guanine triphosphatase-activating protein of p21 r"~ (9, 
10).  Signals  are  then  transmitted  to  the  nucleus  through 
~Abbreviations used in this  paper: anti-p., goat anti-mouse IgM; AP, alkaline 
phosphatase; BCR., B cell antigen receptor; GST, glutathione S-trans- 
ferase; me, motheaten; me  ~, viable motheaten; PLC% phospholipase Cy; 
PTK, protein tyrosine kinase; PTP, protein tyrosine phosphatase; PY, 
phosphotyrosine; SHP-1, Src homology region 2  domain-containing 
phosphatase I; SH2, Src homology region 2; SLP-76, SH2-containing 
leukocyte-specific  protein of  76 kD. 
various pathways whose integrations regulate the processes 
of activation,  proliferation,  differentiation,  or  cell  death. 
The degree of substrate tyrosine phosphorylation is tightly 
controlled by action of PTKs and protein tyrosine phos- 
phatases (PTPs) (11-13). The complexity of these interac- 
tions  is  underscored by  the  fact  that  PTK can,  in  some 
cases, be a target of PTP action. One such example of this 
includes CD45,  a receptor-type PTP that has been shown 
to play a critical role in initial activation of PTKs both in T 
(14,  15) and in B  cells (16-19). However, regulatory roles 
of other PTPs in BCR-mediated signal  transduction have 
not been well characterized. 
SHP-1, previously named HCP (20),  PTPIC (21), SHP 
(22),  and SH-PTP1  (23),  is an intracellular PTP that con- 
tains  two  tandemly linked  Src homology region 2  (SH2) 
domains at the NH  2 terminus followed by a catalytic do- 
main. It has been demonstrated that the immunological ab- 
normalities  of the  motheaten  (me) and  viable  motheaten 
(me  v)  mice are caused by mutations in the gene encoding 
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residue  in  the  NH2-terminal  SH2  domain  resulting  in no 
SHP-1  production,  whereas  the  me" mutation  is  a  thymi- 
dine to adenine transversion in the catalytic domain, result- 
ing  in  an  enzymatically  deficient  SHP-1  variant  (24-26). 
Mice homozygous for the me and me" display autoimmune 
and  immunodeficiency  disease  and  die  at  3  and  9  wk  of 
age, respectively (27, 28). The abnormality includes expan- 
sion of CD5 + B-1  B  cells  (29),  reduced numbers of B  cell 
progenitors  in  the  bone  marrow  and  conventional B-2  B 
cells  in the periphery (30), and functional defects in T  and 
NK  cells  (31,  32).  Recent  studies  (33)  have  shown  that 
SHP-1  negatively regulates BCR signaling and is involved 
in determining the threshold for negative selection. SHP-1 
has  been  shown  to be  involved in  negative  regulation  of 
BCR signaling by FcyRIIB1 (34). Although the biochem- 
istry of the  events  remains poorly understood,  it has been 
shown  that  SHP-1  is  constitutively  associated  with  BCR 
complex and that BCR ligation induces tyrosine phospho- 
rylation of SHP-1  and its  dissociation from BCR  complex 
(35).  These results strongly suggest a crucial role of SHP-1 
in the fine tuning of BCR signaling. 
In this  study,  we  investigated  the  mechanisms whereby 
SHP-1  regulates  BCR-initiated  signal  transduction  by 
identifying  the  nature  of SHP-l-associated  proteins.  Our 
results  demonstrate  that  SHP-1  is  associated  with  at  least 
three  species  of tyrosine-phosphorylated proteins  of ~75, 
1 I0, and  150 kD, both in vitro and in vivo. We identified 
the protein of 75 kD to be the SH2-containing leukocyte- 
specific protein of 76 kD, SLP-76. Although BCR ligation 
is  required  for the  significant induction  of tyrosine  phos- 
phorylation of SLP-76, the association of SHP-1 with SLP- 
76 was constitutively observed both in an immature B  cell 
line and in normal splenic B  cells.  Thus,  SLP-76, and two 
as yet unidentified  proteins  of 110  and  150  kD,  may play 
roles in the action of SHP-1 in B cells. 
Materials and Methods 
Mice.  C57BL/6 CrSlc (B6) mice were purchased from Japan 
SLC, Inc. (Hamamatsu, Japan),  and were used at 6-8 wk of age. 
Cells.  WEHI-231  cells were  obtained  from  the  American 
Type Culture Collection (Rockville, MD) and were maintained 
in RPMI  1640  (Nikken Bio Medical Laboratory, Kyoto, Japan) 
supplemented with  10% fetal bovine serum (Bioserum,  Canter- 
bury, Australia), 50 btM 2-ME, 100 b~g/ml streptomycin, and 100 
U/ml penicillin  (17).  Splenic  B  cells were prepared by treating 
spleen  cells from B6 mice with anti-Thy-l.2 mAb and rabbit  C, 
as described  previously (36). 
Abs.  Goat anti-mouse lgM (anti-Ix) Ab was purchased from 
Cappel,  Organon  Teknika  Corp.  (Durham,  NC).  Anti-mouse 
HS1  mAb  was  purchased  from  Sumitomo  Electric  Industries 
(Osaka, Japan).  Polyclonal rabbit  anti-human SHP-1 Ab, which 
reacts  with  the  mouse product,  and anti-phosphotyrosine  (Pu 
mAb  4GlO  were  purchased  from  Upstate  Biotechnology,  Inc. 
(Lake Placid, NY). Polyclonal rabbit  anti-mouse Syk Ab was de- 
scribed previously (19). Polyclonal anti-SLP-76 Ab was raised by 
immunizing a sheep  with mouse SLP-76 (amino acids 136-235) 
expressed as a glutathione S-transferase  (GST) fusion protein, and 
was  provided generously by Dr.  Gary Koretzky (University  of 
Iowa).  Alkaline  phosphatase  (AP)-conjugated  goat  anti-mouse 
lgG was obtained from Bio-Rad Laboratories  (Richmond, CA), 
and  AP-conjugated  mouse  anti-rabbit  IgG  and  donkey  anti- 
sheep  IgG  were  from Jackson  ImmunoResearch  Laboratories, 
Inc. (West Grove, PA). 
Preparation of GST Fusion Proteins.  The SH2 domains of mu- 
rine SHP-1  were expressed  in Escherichia coli XL1-Blue as GST 
fusion  proteins,  cDNAs  corresponding  to  the  NH2-terminal 
(amino  acids  4-100),  COOH-terminal  (amino  acids  110-213), 
and both (amino acids 4-213) SH2 domains of SHP-1 were am- 
plified by PCR and cloned into pGEX-4T3 (Pharmacia Biotech- 
nology, Uppsala,  Sweden).  Fusion proteins  were  expressed  and 
affinity purified with glutathione-Sepharose 4B (Pharmacia  Bio- 
technology) as described  previously (37). 
lmmunoprecipitation,  Protein Precipitation,  and  Western  Blot Anal- 
ysis.  Immunoprecipitation and Western  analysis were performed 
as described  previously (18,  19). Cells (3 X  107) were suspended 
in  5 ml RPMI  1640  supplemented  with  20  mM  Hepes,  incu- 
bated for 1 h at 37~  and then stimulated  for 5 min with 25 Ixg/ 
ml anti-t*  Ab. Reactions were stopped with 25 ml ice-cold PBS 
containing  1 mM  Na3VO4  and  2  mM  EDTA  (PBS-VE).  The 
cells were washed twice with  PBS-VE,  and lysed  in  1 ml  lysis 
buffer (1% NP-40,  20 mM Tris-HC1, pH 7.5,  137  mM  NaCI, 
10% glycerol,  1 mM Na3VO4,  2 mM EDTA, 1 mM PMSF, 20 
~M  leupeptin,  and 0.15  U/ml aprotinin).  After centrifugation, 
the supernatants  were precipitated  with GST-SHP-1-SH2 fusion 
proteins or immunoprecipitated with protein G-Sepharose cou- 
pled with  anti-SHP-1  Ab or anti-SLP-76 Ab.  Immunoprecipi- 
rates were washed five  times  in  lysis buffer,  boiled in  reducing 
Laemmli SDS sample buffer,  and subjected to 7.5% SDS-PAGE 
followed by transfer  to  a  nitrocellulose  membrane.  The  mem- 
branes were then incubated overnight with anti-PY mAb or anti- 
HS1, anti-Syk, anti-SHP-1, or anti-SLP-76 Ab.  The blots  were 
visualized  by incubating with  AP-linked  goat anti-mouse  lgG, 
mouse anti-rabbit IgG, or donkey anti--s'heep IgG, and then de- 
veloped with  nitro  blue  tetrazolium  and  5-bromo-4-chloro-3- 
indolyl phosphate. 
Results  and Discussion 
The SH2 Domains  of SHP-1  Bind At Least  Three Species of 
Phosphoproteins.  To  begin  to  address  possible  roles  for 
SHP-1  in BCR-mediated  signal transduction,  we first ex- 
amined what B  cell proteins  could associate with the SH2 
domains  of SHP-1.  Total  cell lysates were  prepared  from 
unstimulated  or  anti-~--stimulated  WEHI-231  cells.  Ly- 
sates  were  precipitated  with  the  SH2  domains  of SHP-1 
expressed  as GST fusion proteins,  then subjected  to SDS- 
PAGE and immunoblotting with anti-PY mAb. As shown 
in  Fig.  1 A,  a  GST  fusion  protein  containing  NH2-  and 
COOH-terminal  SH2  domains  (SH2-N+C)  of  SHP-I 
precipitated  two  phosphoproteins  of ~'-,75 kD,  a  110-kD 
phosphoprotein,  and  a  150-kD  phosphoprotein  from 
BCR-stimulated  cell lysates.  To examine the relative  con- 
tribution of the two SH2 domains to these protein-protein 
interactions,  we constructed GST fusion proteins  contain- 
ing either the  NH2- or the COOH-terminal  SH2 domain 
of SHP-1.  The  NH2-terminal  SH2  domain,  when  ex- 
pressed alone (SH2-N), bound to proteins of"~  and 110 
kD as efficiently as did the control SH2-N + C, whereas the 
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reduced  (Fig.  1 A).  In contrast,  the COOH-terminal  SH2 
domain  (SH2-C)  alone  did  not  precipitate  any  of these 
proteins  (Fig.  1 A). Thus, it appears that the SHP-1  associ- 
ation with the 75- and 110-kD proteins is mediated mainly 
by  the  SH2-N,  but  both  SH2  domains  are  required  for 
maximal SHP-1 interaction with the 150-kD protein. 
The Binding of SHP-1  to the Associated  Proteins Is  Observed 
in Intact  Cells.  To  investigate  whether  the  in  vitro  bind- 
ing of SHP-1  to  the  proteins  described  above is  also  ob- 
served in intact  cells,  WEHI-231  cell  lysates were  immu- 
noprecipitated with anti-SHP-1  Ab, and then subjected to 
Western blot analysis with  anti-PY mAb.  The experiment 
shown  in  Fig.  1  B  demonstrates  that  SHP-1  immunopre- 
cipitates  contain  similar  species  of phosphoproteins  of 75, 
110,  and  150  kD  in  anti-~t~stimulated  cell  lysates.  Al- 
though SHP-1  has been shown to bind  to a  44-kD phos- 
phoprotein  in  BCR-stimulated  WEHI-231  cells  (38),  we 
did  not  observe  this  association.  The  reason  for  this  dis- 
crepancy  with  previously  published  work  is  not  known, 
but may be due to cloned variation in WEHI-231  (39). As 
previously reported (35, 38, 40), we found that BCR stim- 
ulation induced tyrosine phosphorylation of SHP-1. Taken 
together,  these  data indicate  that SHP-1  is associated both 
in vitro  and in vivo with at least three species of tyrosine- 
phosphorylated proteins. 
Identification of the SLIP-1-binding 75-kD Protein as SLpo 76. 
To characterize the nature of the SHP-l-associated protein 
of"-'75 kD, we used Ab to search for candidate phosphoty- 
rosine-containing signaling molecules in this similar molec- 
ular weight range.  We first examined whether  HS1,  a 75- 
kD  protein  implicated  in  B  cell  apoptosis  (41),  or Syk,  a 
PTK of 72 kD (5,  6),  binds to SHP-1  in WEHI-231  cells. 
However,  neither  anti-HS1  nor anti-Syk Ab reacted with 
anti-SHP-1  immunoprecipitates  or the SH2-N+C  precip- 
itates,  although both Abs could detect a protein  of appro- 
priate  size in total  cell lysates,  indicating that phosphopro- 
tein (pp)75 is not HS1 or Syk (data not shown). 
We next examined the possibility that pp75 is SLP-76, a 
recently identified leukocyte-specific phosphoprotein of 76 
kD  (42).  Total  cell  lysates  of WEHI-231  cells,  either  un- 
stimulated  or stimulated  with  anti-I*  Ab  for 5  min,  were 
precipitated  with  anti-SHP-1  Ab or anti-SLP-76  Ab,  and 
then  immunoblotted  with  anti-SLP-76  Ab  or  anti-PY 
mAb.  Experiments  shown  in  Fig.  2  A  revealed  that  anti- 
SHP-1  immunoprecipitates  contain a protein reactive with 
anti-SLP-76 Ab,  irrespective  of anti-p~  stimulation.  How- 
ever,  significant  tyrosine  phosphorylation  of SLP-76  was 
observed after BCK ligation  (Fig.  2  /3). We further tested 
whether  SHP-1  could be  detected in  anti-SLP-76  immu- 
noprecipitates.  Fig.  2  C  demonstrates  that anti-SLP-76 Ab 
coimmunoprecipitates SHP-1  even in the absence of anti-p, 
stimulation,  strongly suggesting constitutive  association  of 
SHP-1  with  SLP-76.  The  time  course  experiments  re- 
vealed  that  the  association  of SHP-1  with  SLP-76  is  de- 
tected even at 1 h  after BCR ligation (data not shown). 
Figure 1.  SHP-I binds at least three species of proteins both in vitro (A) and in vivo (B). (A) Lysates of WEHI-231 cells, either unstimulated (-) or 
stimulated with anti-p. Ab (25 p~g/ml) for 5 rnin (+), were incubated with either SHP-1-SH2-N-GST  (SH2-N), SHP-1-SH2-C-GST  (SH2-C), and 
SHP-I-SH2-N+C-GST (SH2-N+C)  fusion proteins, or GST alone. Bound proteins were resolved by SDS-PAGE and immunoblotted with anti-PY 
mAb. (B) Lysates of WEHI-231 cells, either unstimulated (-) or anti-bt stimulated as above (+), were immunoprecipitated with anti-SHP-1 Ab, sub- 
jected to SDS-PAGE, and immunoblotted with anti-SHP-1 Ab or anti-PY mAb. The molecular mass markers used are shown in kilodaltons on the left. 
459  Mizuno et al. Figure  2.  SHP-1 is associated constitutively with SLP-76 in WEHI-231  cells. Lysates  of anti-p~-stimulated (+) or unstimulated (-) WEHI-231  cells 
were precipitated with anti-SLP-76 Ab or anti-SHP-1 Ab, subjected to SDS-PAGE, and immunoblotted with anti-SLP-76 Ab (A), anti-PY mAb (B), or 
anti-SHP-1 Ab (C). The molecular mass markers used are shown in kilodaltons on the left. 
To  confirm the  association  of SHP-1  with  SLP-76,  de- 
pletion  experiments were performed.  Lysates from anti-bt- 
stimulated WEHI-231  cells were precipitated with SHP-1- 
SH2-N+C.  The SHP-l-binding  proteins were dissociated 
with  heating  in  SDS  sample buffer,  diluted  in  lysis buffer, 
and then immunoprecipitated with anti-SLP-76 Ab or nor- 
mal sheep serum. After immunoprecipitation,  the superna- 
tants  were  precipitated  with  the  SH2-N+C,  and  probed 
with  anti-PY  mAb.  As  shown  in  Fig.  3,  pp75  was  almost 
completely removed by anti-SLP immunoprecipitation,  in- 
dicating  that most of the proteins  bound  to  the  SH-N+C 
are  SLP-76.  Thus,  SHP-1  is constitutively  associated  with 
SLP-76  and the association  appears to be stable  during  the 
early phase of BCR-initiated  signal transduction. 
Association  of SHP-1  with  SLP-76  in  Normal  Splenic  B 
Cells.  Finally,  we  investigated  whether  the  constitutive 
association  of SHP-1  with  SLP-76  is  detected  in  normal 
splenic  B  cells.  Purified B  cells were  prepared  from spleen 
cells by treatment with  anti-Thy-1  mAb and  C.  As shown 
in Fig. 4, anti-SHP-1  immunoprecipitates  of splenic B  cells 
contained  proteins  reactive with  anti-SLP-76  Ab,  suggest- 
ing that SHP-1  is constitutively  associated with  SLP-76  in 
normal B  cells as well. 
Accumulating  evidence  suggests  that  SHP-1  is involved 
in  negative  regulation  or  termination  of BCR  signaling. 
For instance,  using B  cells from anti-hen  egg lysozyme Ig 
transgenic mice crossed to  me  v mice,  Cyster and  Goodnow 
(33)  have demonstrated  that BCR  triggers  accelerated  and 
greater  calcium  responses  in  SHP-l-deficient  cells.  These 
investigators  also showed that  SHP-1  increases  a  threshold 
for negative selection of B  cells. D'Ambrosio et al. (34) fur- 
ther  demonstrated  that  upon  coligation  of Fc~/RIIB1  and 
BCR,  SHP-1  is  recruited  to  a  13-amino  acid  tyrosine- 
phosphorylated  motif of FcyRIIB1.  After binding  the  re- 
ceptor, the enzymatic activity of SHP-1  is increased, leading 
to  inhibition  of BCR  signaling  (34).  Fc~/RIIBl-mediated 
negative signaling is defective in  me mutant  mice  (34,  35). 
Additionally,  me  and  me"  B  cells  exhibit  an  increased  re- 
sponse  to  suboptimal  dose  of anti-I* Ab  (35).  It  was  also 
shown  that  SHP-1  is  constitutively  associated  with  BCR 
complex,  possibly  regulating  the  phosphorylation  state  of 
BCR  complex components,  and that BCR ligation induces 
dissociation  of SHP-1  from the BCR  complex (35),  How- 
ever,  to  elucidate  the  exact  mechanisms  of SHP-1  action 
and to understand  the pathogenesis  of me mutants,  delinea- 
tion  of the  molecular  interactions  involving  SHP-1  is  es- 
sential. 
The present study was designed to begin such investiga- 
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Lysates of anti-lx~stimulated WEHI-231  cells were  precipitated with 
SH2-N+C. The SHP-l-binding  fraction was dissociated, and immuno- 
precipitated with  anti-SLP-76 Ab  (right  lane) or normal sheep serum 
(NSS;  left lane). The remaining proteins were precipitated again with the 
SH2-N+ C, subjected to SDS-PAGE, and blotted with anti-PY mAb. 
Figure 4.  Constitutive association between SHP-1 and SLP-76 is ob- 
served in splenic B cells. Lysates from T-depleted spleen cells, either be- 
fore (-) or after (+) anti-p, stimulation, were immunoprecipitated with 
anti-SHP-1 or anti-SLP-76 Ab, resolved by SDS-PAGE, and immuno- 
blotted with anti-SLP-76 Ab. 
tions.  The results presented demonstrate that SHP-1  is asso- 
ciated  with  at  least  three  tyrosine-phosphorylated  proteins 
through  its  SH2  domains.  One  of the  SHP-l-associated 
proteins  was  identified  as  SLP-76,  a  hematopoietic  cell- 
specific protein of 533 amino acids that has an NH2-termi- 
nal  region  with  potential  tyrosine  phosphorylation  sites,  a 
central  proline-rich  region,  and  a  COOH-terminal  SH2 
domain  (42).  This  protein-protein  interaction  is  constitu- 
tively observed not only in the WEHI-231 immature B cell 
line but also in splenic B  cells,  supporting physiological rel- 
evance of SHP-1-SLP-76 association. One possible molec- 
ular basis  of this interaction is that the binding of the SHP-1 
SH2  domain  to  SLP-76  occurs  independently  of tyrosine 
phosphorylation. Mternatively,  SH2 domain of SHP-1  can 
interact  even with meagerly tyrosine-phosphorylated SLP- 
76.  Determination  of the  region(s)  of SLP-76  responsible 
for the SHP-1 binding should resolve this issue. 
Functional  relevance  of SHP-1-SLP-76  interaction  in 
the  cascades of BCR  signaling also needs to be elucidated. 
Analysis in T  cells has suggested that upon TCR  activation, 
SLP-76 is  tyrosine phosphorylated and associated with  the 
adaptor protein  Grb2,  PLC~/1,  and uncharacterized  pp36/ 
38 (42). SLP-76 may thus be implicated in linking PTK ac- 
tivation with Ras signaling and/or PLC~/1 activation through 
its Grb2 association. Whether SLP-76 in B  cells behaves in 
a  similar  manner  or interacts  with  unique  signaling mole- 
cules  is  critical  to  the  understanding  of SHP-1  function. 
Also, information on how the absence of SHP-1  affects the 
mode of action of SLP-76 may help us to understand better 
the  me pathology. 
In  addition  to  SLP-76,  SHP-1  was  shown  to  bind  to 
110-  and  150-kD  phosphoproteins  in WEHI-231  cells.  It 
has recently been reported that upon BCR ligation, SHP-1 
is  recruited  to  tyrosine-phosphorylated  CD22,  a  BCR 
complex-associated  lectin  of 120--135  kD  (40,  43),  and is 
activated  (40).  Our  preliminary  studies  showed  that  anti- 
CD22 Ab does not detect a band in anti-SHP-1  or SHP-1 
SH2  precipitates.  Whether  SHP-1  associates  with  other 
species of proteins is currently under study. 
In summary, our studies demonstrate that SHP-1  is con- 
stitutively associated with SLP-76 in WEHI-231 immature 
B  cell line and splenic B  cells,  mainly through NH2-termi- 
nal SH2 domain of SHP-1. Thus, SLP-76 is vital to the un- 
derstanding of SHP-l-mediated  signaling in B  cells and of 
me pathogenesis. 
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